Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Klaviyo (KVYO) Liabilities and Shareholders Equity (2022 - 2026)

Klaviyo has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $1.5 billion for Q1 2026.

  • Quarterly results put Liabilities and Shareholders Equity at $1.5 billion for Q1 2026, up 13.09% from a year ago — trailing twelve months through Mar 2026 was $6.0 billion (up 20.22% YoY), and the annual figure for FY2025 was $1.6 billion, up 24.13%.
  • Liabilities and Shareholders Equity reached $1.5 billion in Q1 2026 per KVYO's latest filing, down from $1.6 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.6 billion in Q4 2025 and bottomed at $629.1 million in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.2 billion (2024), compared with a mean of $1.2 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity skyrocketed 73.12% in 2023 before it rose 11.37% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $629.1 million in 2022, then soared by 73.12% to $1.1 billion in 2023, then grew by 16.92% to $1.3 billion in 2024, then grew by 24.13% to $1.6 billion in 2025, then decreased by 3.61% to $1.5 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for KVYO at $1.5 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 billion in Q3 2025.